Sign In
Buy ESTA
$92.54
-0.94 (-1.01%)
At Close: Jul 31, 2026
Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday
05:52am, Thursday, 20'th Oct 2022 Benzinga
Gainers
Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of E
Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session
04:30pm, Wednesday, 19'th Oct 2022 Benzinga
Gainers
SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share.
Scopus BioPharma Inc. (NASDAQ:
Establishment Labs (ESTA) Stock Falls 12% on Hindenburg Short Report
11:30am, Wednesday, 19'th Oct 2022
Establishment Labs (NASDAQ: ESTA ) stock is plunging lower today after short seller Hindenburg Research released a short report on the company. Establishment operates in the breast augmentation busine
Establishment Labs stock sinks toward 21-month low after short seller Hindenburg takes aim
09:22am, Wednesday, 19'th Oct 2022
Shares of Establishment Labs Holdings Inc. ESTA, -1.50% tumbled 21.7% toward a 21-month low in premarket trading Wednesday, after short-seller Hindenburg Research took aim at the silicone breast impla
Analyst Ratings for Establishment Labs Hldgs
08:15pm, Friday, 14'th Oct 2022 Benzinga
Analysts have provided the following ratings for Establishment Labs Hldgs (NASDAQ:ESTA) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
3
5 Analysts Have This to Say About Establishment Labs Hldgs
03:43pm, Friday, 14'th Oct 2022 Benzinga
Over the past 3 months, 5 analysts have published their opinion on Establishment Labs Hldgs (NASDAQ:ESTA) stock. These analysts are typically employed by large Wall Street banks and tasked with unders
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
02:05pm, Thursday, 13'th Oct 2022 Benzinga
Upgrades
TD Securities upgraded the previous rating for BCE Inc (NYSE:BCE) from Hold to Buy. In the second quarter, BCE showed an EPS of $0.68, compared to $0.68 from the year-ago quarter. The current
Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2022
02:11pm, Wednesday, 24'th Aug 2022 Benzinga
Upgrades
According to Citigroup, the prior rating for Cyxtera Technologies Inc (NASDAQ:CYXT) was changed from Neutral to Buy. The current stock performance of Cyxtera Technologies shows a 52-week-hig
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates
09:15pm, Monday, 08'th Aug 2022 Zacks Investment Research
Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of -114.29% and 8.97%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for
Establishment Labs Holdings, Inc. (ESTA) CEO Juan Jose Chacon Quiros on Q2 2022 Results Earnings Call Transcript
08:29pm, Monday, 08'th Aug 2022
Establishment Labs Holdings, Inc. (NASDAQ:ESTA ) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Juan Jose Chacon Quiros - Founder and CEO Rajbir Denhoy - CFO Conferenc
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates
06:48pm, Monday, 08'th Aug 2022
Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of -114.29% and 8.97%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for
Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates
11:15am, Thursday, 04'th Aug 2022 Zacks Investment Research
Biodesix, Inc. (BDSX) delivered earnings and revenue surprises of 14.89% and 28.75%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Teladoc (TDOC) Reports Q2 Loss, Tops Revenue Estimates
09:25pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
Teladoc (TDOC) delivered earnings and revenue surprises of 38.03% and 0.94%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Establishment Labs to Present at the Jefferies Healthcare Conference
08:00am, Monday, 06'th Jun 2022
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast a
Establishment Labs Holdings, Inc. (ESTA) CEO Juan Jose Chacon Quiros on Q1 2022 Results - Earnings Call Transcript
10:46pm, Monday, 09'th May 2022
Establishment Labs Holdings, Inc. (NASDAQ:ESTA ) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Juan Jose Chacon Quiros - Founder, Chief Executive Officer & Executive Dir
